{
    "clinical_study": {
        "@rank": "50159", 
        "arm_group": [
            {
                "arm_group_label": "Lifitegrast", 
                "arm_group_type": "Experimental", 
                "description": "Lifitegrast Ophthalmic Solution (5.0%)"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to evaluate the safety and efficacy of lifitegrast ophthalmic\n      solution compared to placebo in the treatment of dry eye."
        }, 
        "brief_title": "A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Dry Eye", 
        "condition_browse": {
            "mesh_term": [
                "Keratoconjunctivitis Sicca", 
                "Dry Eye Syndromes"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Willing and able to read, sign and date the informed consent and HIPAA documents\n\n          -  Willing and able to comply with all study procedures\n\n          -  Be at least 18 years of age\n\n          -  Patient-reported history of dry eye in both eyes\n\n          -  A negative urine pregnancy test if female of childbearing potential and must use\n             adequate birth control throughout the study period\n\n          -  Artificial tear use within the past 30 days\n\n        Exclusion Criteria:\n\n          -  Any ocular condition that, in the opinion of the Investigator, could affect study\n             parameters including, but not limited to, active ocular infection, ocular\n             inflammation, glaucoma, and/or diabetic retinopathy\n\n          -  Unwilling to avoid wearing contact lenses for 7 days prior to first visit and for the\n             duration of the study\n\n          -  Any blood donation or significant loss of blood within 56 days of Visit 1\n\n          -  Any history of immunodeficiency disorder, positive HIV, hepatitis B, C, or evidence\n             of acute active hepatitis A (anti-HAV IgM), or organ or bone marrow transplant.\n\n          -  Use of any prohibited medications at any time during the study unless otherwise\n             specified\n\n          -  Any significant illness that could interfere with study parameters\n\n          -  History of laser assisted in situ keratomileusis (LASIK) or similar type of corneal\n             refractive surgery within 12 months prior to first visit, and/or any other ocular\n             surgical procedure within 12 months prior to first visit; or any scheduled ocular\n             surgical procedure during the study period.\n\n          -  Known history of alcohol and/or drug abuse\n\n          -  Subjects with Dry eye secondary to scarring or destruction of conjunctival goblet\n             cells (as with Vitamin A deficiency)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "720", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01743729", 
            "org_study_id": "1118-DRY-300"
        }, 
        "intervention": [
            {
                "arm_group_label": "Lifitegrast", 
                "description": "Lifitegrast Ophthalmic Solution 5.0%", 
                "intervention_name": "Lifitegrast", 
                "intervention_type": "Drug", 
                "other_name": "SAR 1118"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo for Lifitegrast Ophthalmic Solution 5.0%", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "SAR 1118", 
        "lastchanged_date": "April 25, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Artesia", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90701"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hemet", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92545"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lancaster", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "93534"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mission Hills", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91345"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montebello", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90640"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newport Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92663"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Petaluma", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94954"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rancho Cordova", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95670"
                    }, 
                    "name": "OPUS-2 Investigational SIte"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Danbury", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06810"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Myers", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33901"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hoffman Estates", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60169"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46260"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Albany", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "47150"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lexington", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40509"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Paul", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55082"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chesterfield", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63017"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Des Peres", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63131"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Independence", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "64055"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "64111"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63090"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10036"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wantagh", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11793"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44115"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19148"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77034"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77055"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "League City", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77573"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78229"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78209"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norfolk", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23502"
                    }, 
                    "name": "OPUS-2 Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)", 
        "overall_official": {
            "affiliation": "SARcode Bioscience", 
            "last_name": "Charles Semba, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Corneal staining score", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }, 
            {
                "measure": "Patient-reported dryness score", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }, 
            {
                "measure": "Safety and tolerability of lifitegrast Ophthalmic Solution (5.0%) compared to placebo, including incidence and severity of ocular and non-ocular adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Week 12"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01743729"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Corneal fluorescein score", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }, 
            {
                "measure": "Conjunctival lissamine staining", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }, 
            {
                "measure": "Eye discomfort scores", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }
        ], 
        "source": "Shire", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shire", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}